Cardinal Partners

Vividion Therapeutics, Inc. is a biotechnology company based in San Diego, California, that focuses on developing innovative therapeutics to address significant unmet medical needs. Established in 2013, Vividion utilizes a pioneering platform for proteome-wide small molecule drug discovery, which combines advanced synthetic chemistry techniques with chemical proteomics. This approach allows the company to expand the druggable proteome and target challenging proteins, ultimately enabling the discovery of transformative treatments for serious illnesses. Vividion's scientific foundation stems from experts in chemical biology and synthetic chemistry at The Scripps Research Institute, reflecting its commitment to advancing therapeutics that can significantly improve patient outcomes.

Cureatr Inc. is a New York-based company that specializes in mobile care coordination solutions for healthcare providers. Founded in 2011, it offers a cloud-based medication management software designed to optimize patient care, particularly focusing on post-discharge medication reconciliation. The platform combines HIPAA-secure text messaging with workflow navigation tools, facilitating communication and coordination among healthcare professionals. Cureatr's software features an inbuilt dashboard that curates and analyzes patients' medication history, enabling providers to respond to real-time events and improve their interactions with patients. By streamlining these processes, Cureatr enhances the overall quality of patient care.

Founded in 2015, Prealize Health employs machine learning to proactively identify high-risk individuals in healthcare settings. By predicting future health risks, the company enables health plans, employers, and providers to intervene early, improve care quality, and manage costs effectively.

Vividion Therapeutics, Inc. is a biotechnology company based in San Diego, California, that focuses on developing innovative therapeutics to address significant unmet medical needs. Established in 2013, Vividion utilizes a pioneering platform for proteome-wide small molecule drug discovery, which combines advanced synthetic chemistry techniques with chemical proteomics. This approach allows the company to expand the druggable proteome and target challenging proteins, ultimately enabling the discovery of transformative treatments for serious illnesses. Vividion's scientific foundation stems from experts in chemical biology and synthetic chemistry at The Scripps Research Institute, reflecting its commitment to advancing therapeutics that can significantly improve patient outcomes.

Vividion Therapeutics, Inc. is a biotechnology company based in San Diego, California, that focuses on developing innovative therapeutics to address significant unmet medical needs. Established in 2013, Vividion utilizes a pioneering platform for proteome-wide small molecule drug discovery, which combines advanced synthetic chemistry techniques with chemical proteomics. This approach allows the company to expand the druggable proteome and target challenging proteins, ultimately enabling the discovery of transformative treatments for serious illnesses. Vividion's scientific foundation stems from experts in chemical biology and synthetic chemistry at The Scripps Research Institute, reflecting its commitment to advancing therapeutics that can significantly improve patient outcomes.

LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Ivenix, Inc. is a medical technology company based in North Andover, Massachusetts, specializing in the development of advanced intravenous (IV) infusion systems. Founded in 2001 and originally known as Fluidnet Corporation, Ivenix offers a next-generation infusion management platform that utilizes pneumatic technology to enhance the accuracy of fluid delivery. This innovative system is designed to measure and control flow regardless of factors such as bag height, backpressure, patient movement, and fluid viscosity. Additionally, the platform manages patient infusion data and integrates seamlessly with clinical information systems, ensuring precise and continuous infusion delivery in hospital settings. Ivenix aims to revolutionize infusion therapy worldwide by combining state-of-the-art information technology with user-friendly design, thereby improving patient care and safety.

Cureatr Inc. is a New York-based company that specializes in mobile care coordination solutions for healthcare providers. Founded in 2011, it offers a cloud-based medication management software designed to optimize patient care, particularly focusing on post-discharge medication reconciliation. The platform combines HIPAA-secure text messaging with workflow navigation tools, facilitating communication and coordination among healthcare professionals. Cureatr's software features an inbuilt dashboard that curates and analyzes patients' medication history, enabling providers to respond to real-time events and improve their interactions with patients. By streamlining these processes, Cureatr enhances the overall quality of patient care.

LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

aTyr Pharma, Inc., established in 2005 and headquartered in San Diego, California, is a biotherapeutics company dedicated to discovering and developing innovative medicines based on novel immunological pathways. The company's primary focus is efzofitimod (formerly ATYR1923), a fusion protein currently in clinical trials for treating interstitial lung diseases by modulating immune engagement through the neuropilin-2 receptor. aTyr Pharma has collaborations with academic institutions and industry partners, including the University of Nebraska Medical Center, CSL Behring, Boston Children's Hospital, Kyorin Pharmaceutical Co., Ltd., and the Medical University of South Carolina, to advance its pipeline of immunomodulatory therapeutics derived from tRNA synthetases. The company is backed by prominent life sciences investors such as Alta Partners, Cardinal Partners, Domain Associates, and Polaris Ventures.

Teladoc Health connects people worldwide with appropriate healthcare services through its integrated clinical solutions, including telehealth, expert medical opinions, AI-driven analytics, and licensable platform services. With over 2,000 employees, the company operates in 125 countries and 20 languages, partnering with employers, hospitals, health systems, and insurers to transform care delivery.

Privia Health is a technology-driven company that partners with medical groups, health plans, and systems to optimize physician practices. It improves patient experiences and rewards doctors for delivering high-value care, both in-person and virtually. Privia's cloud-based platform focuses on reducing healthcare costs, achieving better outcomes, and enhancing provider well-being.

Cureatr Inc. is a New York-based company that specializes in mobile care coordination solutions for healthcare providers. Founded in 2011, it offers a cloud-based medication management software designed to optimize patient care, particularly focusing on post-discharge medication reconciliation. The platform combines HIPAA-secure text messaging with workflow navigation tools, facilitating communication and coordination among healthcare professionals. Cureatr's software features an inbuilt dashboard that curates and analyzes patients' medication history, enabling providers to respond to real-time events and improve their interactions with patients. By streamlining these processes, Cureatr enhances the overall quality of patient care.

aTyr Pharma, Inc., established in 2005 and headquartered in San Diego, California, is a biotherapeutics company dedicated to discovering and developing innovative medicines based on novel immunological pathways. The company's primary focus is efzofitimod (formerly ATYR1923), a fusion protein currently in clinical trials for treating interstitial lung diseases by modulating immune engagement through the neuropilin-2 receptor. aTyr Pharma has collaborations with academic institutions and industry partners, including the University of Nebraska Medical Center, CSL Behring, Boston Children's Hospital, Kyorin Pharmaceutical Co., Ltd., and the Medical University of South Carolina, to advance its pipeline of immunomodulatory therapeutics derived from tRNA synthetases. The company is backed by prominent life sciences investors such as Alta Partners, Cardinal Partners, Domain Associates, and Polaris Ventures.

Sapphire Digital, established in 2007 and headquartered in Lyndhurst, New Jersey, is a healthcare technology company specializing in cost reduction and care selection. It offers a suite of solutions, including CareSelect, SmartShopper, MEG, and Sapphire 360, which empower consumers, employers, and health plans to make informed decisions about their healthcare, driving down costs and improving quality. These platforms facilitate care shopping, reward cost-conscious employees, provide surgeon and facility quality scores, and support data-driven medical spend reduction. The company, formerly known as Vitals, serves over 280 million people annually.

LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

QPID Health, Inc. is a healthcare IT software company based in Boston, Massachusetts, with additional locations in San Diego, California. The company focuses on delivering a health record intelligence platform that enhances the utility of electronic health records (EHRs) for healthcare institutions and clinicians. Its primary product, the Queriable Programmable Inference Dossier (QPID), enables real-time, clinician-directed queries and analytics at the point of care. By aggregating and processing EHR data, QPID offers context-sensitive information that integrates seamlessly into clinical workflows, thereby improving clinician productivity and decision-making. The platform employs natural language processing and machine learning techniques to provide tailored clinical insights, helping healthcare organizations optimize operations, reduce costs, and enhance patient outcomes. Founded in 2013 by Dr. Michael Zalis and Dr. Mitch Harris, QPID Health addresses the growing need for effective data utilization in healthcare settings.

Vascular Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing therapeutics for patients with type 1 and type 2 diabetes, particularly targeting diabetic nephropathy. Founded in 2005 and headquartered in Research Triangle Park, North Carolina, the company is advancing its lead candidate, VPI-2690B, a subcutaneously administered monoclonal antibody designed to address complications associated with diabetes. This drug binds to a specific molecular target within the αVβ3 receptor, aiming to mitigate the harmful effects of hyperglycemia and improve patient outcomes. Vascular Pharmaceuticals operates at the intersection of biotechnology and healthcare, committed to innovative solutions for diabetes-related complications.

Awarepoint Corporation is a provider of cloud-based real-time locating systems (RTLS) that enhance operational efficiency across various industries, with a strong focus on healthcare. Established in 2002 and headquartered in San Diego, California, the company offers a suite of solutions that includes analytical tools for transforming location data into actionable insights, as well as managed services encompassing analysis, configuration, installation, validation, and training. Awarepoint's RTLS solutions are particularly valuable in acute care hospitals, addressing challenges related to asset management, compliance, and patient throughput. The company also offers a Temperature Monitoring System designed to help medical facilities comply with guidelines for vaccine storage. Awarepoint's integrated platform allows healthcare organizations to optimize workflows and communication, improve staff efficiency, and enhance patient satisfaction, ultimately leading to better clinical and financial outcomes.

LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Medley Health is an innovative, entrepreneurial, technology-driven company. It's backed by top-tier investors and a management team with deep business expertise in healthcare, Internet and web services, as well as next-generation communications technologies.

Verastem, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative treatments aimed at improving the survival and quality of life for cancer patients. Based in Needham, Massachusetts, Verastem markets COPIKTRA (duvelisib), an oral medication indicated for adult patients with relapsed or refractory chronic lymphocytic leukemia and follicular lymphoma after multiple prior therapies. In addition to this approved therapy, the company is advancing its pipeline with the focal adhesion kinase inhibitor defactinib, which is being studied in combination with immunotherapies for various cancers, including pancreatic and ovarian cancers, as well as non-small cell lung cancer. Verastem's research emphasizes inhibiting critical signaling pathways that promote cancer cell survival and tumor growth, particularly those associated with the RAS/MAPK pathway. The company has formed collaborative agreements with Yakult Honsha Co., Ltd. and CSPC Pharmaceutical Group Limited to enhance its development efforts. Founded in 2010, Verastem continues to focus on late-stage development of its anticancer agents.

Teladoc Health connects people worldwide with appropriate healthcare services through its integrated clinical solutions, including telehealth, expert medical opinions, AI-driven analytics, and licensable platform services. With over 2,000 employees, the company operates in 125 countries and 20 languages, partnering with employers, hospitals, health systems, and insurers to transform care delivery.

Awarepoint Corporation is a provider of cloud-based real-time locating systems (RTLS) that enhance operational efficiency across various industries, with a strong focus on healthcare. Established in 2002 and headquartered in San Diego, California, the company offers a suite of solutions that includes analytical tools for transforming location data into actionable insights, as well as managed services encompassing analysis, configuration, installation, validation, and training. Awarepoint's RTLS solutions are particularly valuable in acute care hospitals, addressing challenges related to asset management, compliance, and patient throughput. The company also offers a Temperature Monitoring System designed to help medical facilities comply with guidelines for vaccine storage. Awarepoint's integrated platform allows healthcare organizations to optimize workflows and communication, improve staff efficiency, and enhance patient satisfaction, ultimately leading to better clinical and financial outcomes.

Fluidnet was founded in 2002 by a group of medical device professionals who collectively have over 100+ years of industry experience and product innovations. Based on the seacoast of scenic New Hampshire, Fluidnet is just north of Boston, providing access to a rich medical device community and first-rate research and development skills and facilities.

Verastem, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative treatments aimed at improving the survival and quality of life for cancer patients. Based in Needham, Massachusetts, Verastem markets COPIKTRA (duvelisib), an oral medication indicated for adult patients with relapsed or refractory chronic lymphocytic leukemia and follicular lymphoma after multiple prior therapies. In addition to this approved therapy, the company is advancing its pipeline with the focal adhesion kinase inhibitor defactinib, which is being studied in combination with immunotherapies for various cancers, including pancreatic and ovarian cancers, as well as non-small cell lung cancer. Verastem's research emphasizes inhibiting critical signaling pathways that promote cancer cell survival and tumor growth, particularly those associated with the RAS/MAPK pathway. The company has formed collaborative agreements with Yakult Honsha Co., Ltd. and CSPC Pharmaceutical Group Limited to enhance its development efforts. Founded in 2010, Verastem continues to focus on late-stage development of its anticancer agents.

LifeIMAGE is an online network that enables individuals to exchange medical images. LifeIMAGE is interoperable with the hospital EMR to provide integrated access to medical images, from anywhere. Clinicians can exchange medical images with patients and providers, anywhere. It was founded in 2008 and headquartered in Newton, Massachusetts.

Awarepoint Corporation is a provider of cloud-based real-time locating systems (RTLS) that enhance operational efficiency across various industries, with a strong focus on healthcare. Established in 2002 and headquartered in San Diego, California, the company offers a suite of solutions that includes analytical tools for transforming location data into actionable insights, as well as managed services encompassing analysis, configuration, installation, validation, and training. Awarepoint's RTLS solutions are particularly valuable in acute care hospitals, addressing challenges related to asset management, compliance, and patient throughput. The company also offers a Temperature Monitoring System designed to help medical facilities comply with guidelines for vaccine storage. Awarepoint's integrated platform allows healthcare organizations to optimize workflows and communication, improve staff efficiency, and enhance patient satisfaction, ultimately leading to better clinical and financial outcomes.

Verastem, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative treatments aimed at improving the survival and quality of life for cancer patients. Based in Needham, Massachusetts, Verastem markets COPIKTRA (duvelisib), an oral medication indicated for adult patients with relapsed or refractory chronic lymphocytic leukemia and follicular lymphoma after multiple prior therapies. In addition to this approved therapy, the company is advancing its pipeline with the focal adhesion kinase inhibitor defactinib, which is being studied in combination with immunotherapies for various cancers, including pancreatic and ovarian cancers, as well as non-small cell lung cancer. Verastem's research emphasizes inhibiting critical signaling pathways that promote cancer cell survival and tumor growth, particularly those associated with the RAS/MAPK pathway. The company has formed collaborative agreements with Yakult Honsha Co., Ltd. and CSPC Pharmaceutical Group Limited to enhance its development efforts. Founded in 2010, Verastem continues to focus on late-stage development of its anticancer agents.

aTyr Pharma, Inc., established in 2005 and headquartered in San Diego, California, is a biotherapeutics company dedicated to discovering and developing innovative medicines based on novel immunological pathways. The company's primary focus is efzofitimod (formerly ATYR1923), a fusion protein currently in clinical trials for treating interstitial lung diseases by modulating immune engagement through the neuropilin-2 receptor. aTyr Pharma has collaborations with academic institutions and industry partners, including the University of Nebraska Medical Center, CSL Behring, Boston Children's Hospital, Kyorin Pharmaceutical Co., Ltd., and the Medical University of South Carolina, to advance its pipeline of immunomodulatory therapeutics derived from tRNA synthetases. The company is backed by prominent life sciences investors such as Alta Partners, Cardinal Partners, Domain Associates, and Polaris Ventures.

Fluidnet was founded in 2002 by a group of medical device professionals who collectively have over 100+ years of industry experience and product innovations. Based on the seacoast of scenic New Hampshire, Fluidnet is just north of Boston, providing access to a rich medical device community and first-rate research and development skills and facilities.

Awarepoint Corporation is a provider of cloud-based real-time locating systems (RTLS) that enhance operational efficiency across various industries, with a strong focus on healthcare. Established in 2002 and headquartered in San Diego, California, the company offers a suite of solutions that includes analytical tools for transforming location data into actionable insights, as well as managed services encompassing analysis, configuration, installation, validation, and training. Awarepoint's RTLS solutions are particularly valuable in acute care hospitals, addressing challenges related to asset management, compliance, and patient throughput. The company also offers a Temperature Monitoring System designed to help medical facilities comply with guidelines for vaccine storage. Awarepoint's integrated platform allows healthcare organizations to optimize workflows and communication, improve staff efficiency, and enhance patient satisfaction, ultimately leading to better clinical and financial outcomes.

Teladoc Health connects people worldwide with appropriate healthcare services through its integrated clinical solutions, including telehealth, expert medical opinions, AI-driven analytics, and licensable platform services. With over 2,000 employees, the company operates in 125 countries and 20 languages, partnering with employers, hospitals, health systems, and insurers to transform care delivery.

Inspired Technologies, based in North Huntingdon, PA, is a commercial-stage medical device company specializing in respiratory products for patients with chronic obstructive pulmonary disease (COPD). The company focuses on auto-titration of oxygen delivery through its innovative SmartDose technology. This technology continuously monitors the user's breath rate and automatically adjusts the oxygen dosage based on the individual's activity level. Additionally, Inspired Technologies provides Clinical Oxygen Dose Recorders that allow healthcare providers to track patient responses and optimize performance in real time. The company also offers Viaspire SD Card Software, which enables the uploading and viewing of patient data from SD cards in SmartDose oxygen dosing units. Through these products, Inspired Technologies aims to enhance the quality of life for COPD patients by providing tailored oxygen delivery solutions.

aTyr Pharma, Inc., established in 2005 and headquartered in San Diego, California, is a biotherapeutics company dedicated to discovering and developing innovative medicines based on novel immunological pathways. The company's primary focus is efzofitimod (formerly ATYR1923), a fusion protein currently in clinical trials for treating interstitial lung diseases by modulating immune engagement through the neuropilin-2 receptor. aTyr Pharma has collaborations with academic institutions and industry partners, including the University of Nebraska Medical Center, CSL Behring, Boston Children's Hospital, Kyorin Pharmaceutical Co., Ltd., and the Medical University of South Carolina, to advance its pipeline of immunomodulatory therapeutics derived from tRNA synthetases. The company is backed by prominent life sciences investors such as Alta Partners, Cardinal Partners, Domain Associates, and Polaris Ventures.

Awarepoint Corporation is a provider of cloud-based real-time locating systems (RTLS) that enhance operational efficiency across various industries, with a strong focus on healthcare. Established in 2002 and headquartered in San Diego, California, the company offers a suite of solutions that includes analytical tools for transforming location data into actionable insights, as well as managed services encompassing analysis, configuration, installation, validation, and training. Awarepoint's RTLS solutions are particularly valuable in acute care hospitals, addressing challenges related to asset management, compliance, and patient throughput. The company also offers a Temperature Monitoring System designed to help medical facilities comply with guidelines for vaccine storage. Awarepoint's integrated platform allows healthcare organizations to optimize workflows and communication, improve staff efficiency, and enhance patient satisfaction, ultimately leading to better clinical and financial outcomes.

CodeRyte is a leading provider of computer-assisted coding and clinical data extraction solutions tailored for the healthcare industry. The company offers advanced software products, including CodeAssist, which automates the coding process by integrating with user operational information systems, and CodeComplete, an outsourced coding solution. Additionally, CodeRyte's DataScout tool analyzes physician narratives to extract clinically relevant information from both free-text and structured medical records. By streamlining coding processes and improving data extraction, CodeRyte enables healthcare providers to secure appropriate reimbursements, enhance compliance, and make informed treatment and business decisions. Its solutions are utilized by many prominent physician practices, billing companies, and academic medical centers across the nation, positioning CodeRyte as a vital component of their coding and data-mining operations.

AxoGen specializes in developing treatments for repairing peripheral nerve injuries. It offers products like AVANCE Nerve Graft, Axoguard Nerve Connector, and Avive Soft Tissue Membrane, serving surgeons globally.

Inspired Technologies, based in North Huntingdon, PA, is a commercial-stage medical device company specializing in respiratory products for patients with chronic obstructive pulmonary disease (COPD). The company focuses on auto-titration of oxygen delivery through its innovative SmartDose technology. This technology continuously monitors the user's breath rate and automatically adjusts the oxygen dosage based on the individual's activity level. Additionally, Inspired Technologies provides Clinical Oxygen Dose Recorders that allow healthcare providers to track patient responses and optimize performance in real time. The company also offers Viaspire SD Card Software, which enables the uploading and viewing of patient data from SD cards in SmartDose oxygen dosing units. Through these products, Inspired Technologies aims to enhance the quality of life for COPD patients by providing tailored oxygen delivery solutions.

aTyr Pharma, Inc., established in 2005 and headquartered in San Diego, California, is a biotherapeutics company dedicated to discovering and developing innovative medicines based on novel immunological pathways. The company's primary focus is efzofitimod (formerly ATYR1923), a fusion protein currently in clinical trials for treating interstitial lung diseases by modulating immune engagement through the neuropilin-2 receptor. aTyr Pharma has collaborations with academic institutions and industry partners, including the University of Nebraska Medical Center, CSL Behring, Boston Children's Hospital, Kyorin Pharmaceutical Co., Ltd., and the Medical University of South Carolina, to advance its pipeline of immunomodulatory therapeutics derived from tRNA synthetases. The company is backed by prominent life sciences investors such as Alta Partners, Cardinal Partners, Domain Associates, and Polaris Ventures.

Bioconnect Systems is a medical device company based in Fort Washington, Pennsylvania, founded in 2006. The company specializes in developing innovative surgical implants and techniques aimed at creating precisely controlled vascular connections. Its flagship product, the Optiflow family of sutureless anastomotic connectors, allows for a fast and repeatable method of connecting blood vessels. Bioconnect Systems focuses on improving the performance of arteriovenous fistulae and vascular access grafts, which are particularly beneficial for patients with renal diseases, thereby enhancing the process of vascular connection.

Melinta Therapeutics is a pharmaceutical company dedicated to discovering, developing, and commercializing novel antibiotics to combat drug-resistant infections. Its portfolio includes Baxdela, Vabomere, Orbactiv, and Minocin, treating various bacterial infectious diseases. The company's mission is driven by the urgent need for new therapies against antibiotic-resistant pathogens.

CodeRyte is a leading provider of computer-assisted coding and clinical data extraction solutions tailored for the healthcare industry. The company offers advanced software products, including CodeAssist, which automates the coding process by integrating with user operational information systems, and CodeComplete, an outsourced coding solution. Additionally, CodeRyte's DataScout tool analyzes physician narratives to extract clinically relevant information from both free-text and structured medical records. By streamlining coding processes and improving data extraction, CodeRyte enables healthcare providers to secure appropriate reimbursements, enhance compliance, and make informed treatment and business decisions. Its solutions are utilized by many prominent physician practices, billing companies, and academic medical centers across the nation, positioning CodeRyte as a vital component of their coding and data-mining operations.

CardioOptics is a development-stage medical device company based in Boulder.

[Sirtris Pharmaceuticals](http://www.sirtrispharma.com) (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. via: [Sirtris](http://www.sirtrispharma.com)

Roving Planet, Inc. provides network access control and management solutions for enterprise networks. Its products provide a secure network environment by managing and controlling users, endpoints, connections, and sessions. The company serves enterprise, manufacturing, health, higher education, k-12, and aerospace government industries. Roving Planet, Inc. was founded in 2001 and is headquartered in Westminster, Colorado.

[Sirtris Pharmaceuticals](http://www.sirtrispharma.com) (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes. via: [Sirtris](http://www.sirtrispharma.com)

Momenta Pharmaceuticals, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, that focuses on the discovery and development of innovative therapeutics for rare immune-mediated diseases. The company's product pipeline includes novel therapeutics such as M281, a fully-human monoclonal antibody targeting the neonatal Fc receptor to reduce circulating IgG antibodies; M254, aimed at treating inflammatory diseases; and M230, a recombinant trivalent IgG1 Fc multimer designed for enhanced therapeutic activity. Additionally, Momenta has developed complex generic products, including M-Enoxaparin, a generic version of Lovenox, and M356, a generic of Copaxone for multiple sclerosis. Momenta also has biosimilar programs, including M923, a biosimilar of HUMIRA, and M710, a biosimilar of EYLEA for various eye conditions. Despite previously pursuing the generics and biosimilars market, the company shifted its focus to innovative drug development, with several promising candidates in the pipeline for autoimmune diseases. Momenta was founded in 2001 and operates as a subsidiary of Johnson & Johnson.

Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the discovery, development, and commercialization of RNA interference (RNAi) therapeutics. The company focuses on addressing rare genetic diseases, cardio-metabolic conditions, hepatic infectious diseases, and central nervous system/ocular disorders. Its marketed products include ONPATTRO, a treatment for hereditary transthyretin-mediated amyloidosis, and GIVLAARI, which targets acute hepatic porphyria. Alnylam’s pipeline includes investigational therapies such as givosiran for acute hepatic porphyria, lumasiran for primary hyperoxaluria type 1, and vutrisiran for transthyretin amyloidosis. The company has established strategic alliances with notable partners like Sanofi Genzyme and Regeneron Pharmaceuticals, and it collaborates with Vir Biotechnology on RNAi therapeutics for coronavirus infections. Founded in 2002 and headquartered in Cambridge, Massachusetts, Alnylam Pharmaceuticals is at the forefront of transforming RNAi science into innovative medicines to improve patient outcomes.

Momenta Pharmaceuticals, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, that focuses on the discovery and development of innovative therapeutics for rare immune-mediated diseases. The company's product pipeline includes novel therapeutics such as M281, a fully-human monoclonal antibody targeting the neonatal Fc receptor to reduce circulating IgG antibodies; M254, aimed at treating inflammatory diseases; and M230, a recombinant trivalent IgG1 Fc multimer designed for enhanced therapeutic activity. Additionally, Momenta has developed complex generic products, including M-Enoxaparin, a generic version of Lovenox, and M356, a generic of Copaxone for multiple sclerosis. Momenta also has biosimilar programs, including M923, a biosimilar of HUMIRA, and M710, a biosimilar of EYLEA for various eye conditions. Despite previously pursuing the generics and biosimilars market, the company shifted its focus to innovative drug development, with several promising candidates in the pipeline for autoimmune diseases. Momenta was founded in 2001 and operates as a subsidiary of Johnson & Johnson.

NexCura is a provider of online decision support services aimed at enhancing communication between patients and physicians. The company's applications and custom services are offered through an application service provider model, enabling the collection of comprehensive clinical data. NexCura's tools include the NexProfiler, which integrates clinical evidence with personal concerns and individual patient circumstances to assist in pre-treatment decision-making. Additionally, the company offers patient education and market research services, delivering valuable insights to healthcare organizations, pharmaceutical companies, physicians, and patients alike.

CardioOptics is a development-stage medical device company based in Boulder.

Providing 24-hour healthcare these days is a tough balancing act. Don't perform without a safety net you can trust. At IntelliCare, they know the ropes. They're a management company for medical call centers, and they work closely with health systems, provider networks and physician groups to make their operations a success. They offer experience, flexibility, commitment -- and a wide range of 24-hour telephonic and Web-based medical call center services that let you focus on what you do best. Making people feel better.

Providing 24-hour healthcare these days is a tough balancing act. Don't perform without a safety net you can trust. At IntelliCare, they know the ropes. They're a management company for medical call centers, and they work closely with health systems, provider networks and physician groups to make their operations a success. They offer experience, flexibility, commitment -- and a wide range of 24-hour telephonic and Web-based medical call center services that let you focus on what you do best. Making people feel better.

IC-USA is a business consulting firm that assists both domestic and foreign nationals in establishing investments. It also offers passive investments for investing, which refers broadly to a buy-and-hold portfolio strategy for long-term investment.

Pointshare is a national leader in connecting local healthcare communities with secure, online business services that enhance communication, create efficiencies, and improve the delivery of care. Pointshare is the only company that has developed the technology, infrastructure, and hands-on service to create a proven, practical solution for automating the day-to-day business transactions of healthcare.

Pointshare is a national leader in connecting local healthcare communities with secure, online business services that enhance communication, create efficiencies, and improve the delivery of care. Pointshare is the only company that has developed the technology, infrastructure, and hands-on service to create a proven, practical solution for automating the day-to-day business transactions of healthcare.